Precision medicine from the renal cancer genome.
Genomics is revolutionizing our understanding of the molecular basis of renal cell carcinoma (RCC). The advent of unbiased genome-wide association studies has led to the discovery of previously unrecognized genetic predisposing factors that impact an individual's risk of developing RCC. Moreover, large-scale investigations of somatic alterations of the genomic and transcriptomic landscapes in tumours using next-generation sequencing technology have revealed new information on the molecular pathways that are characteristically disrupted in various RCC subtypes. Sequencing studies have revealed that epigenetic machinery and chromatin remodelling complexes are disrupted in >80% of clear cell RCC tumours, the most common form of the disease. The growing knowledge of subtype-specific molecular abnormalities arising from genomics has opened new avenues towards the development of molecular diagnostics for RCC subtypes, and for the rational design of therapeutic approaches tailored to patients based on the molecular profiles of their tumours. Genomic studies have also pinpointed a possible role of environmental exposure to aristolochic acid, a nephrotoxin, in the genesis of the disease in some regions of central Europe. In this Review, we discuss the impact of genomics in identifying the genes and environmental exposures involved in disease susceptibility, and in discovering the molecular pathways that are disrupted somatically in different RCC subtypes. Further, we explore the possibilities provided by this genomic knowledge in providing a precision medicine approach for diagnosing and treating RCC.
Department of Human Genetics, McGill University, 1205 Doctor Penfield Avenue, Montreal, QC, H3A 1B1, Canada.|McGill University and Genome Quebec Innovation Centre, 740 Doctor Penfield Avenue, Montreal, QC, H3A 0G1, Canada.
Yasser
Y
Riazalhosseini
Department of Human Genetics, McGill University, 1205 Doctor Penfield Avenue, Montreal, QC, H3A 1B1, Canada.|McGill University and Genome Quebec Innovation Centre, 740 Doctor Penfield Avenue, Montreal, QC, H3A 0G1, Canada.
Mark
M
Lathrop
D002292:Carcinoma, Renal Cell / Q000175:diagnosis / Q000235:genetics* / Q000628:therapy; D016678:Genome; D006801:Humans; D007680:Kidney Neoplasms / Q000175:diagnosis / Q000235:genetics* / Q000628:therapy; D009154:Mutation; D057285:Precision Medicine
J Natl Cancer Inst. 1984 Feb;72(2):275-84
6582315
Cancer Cell. 2014 Sep 8;26(3):319-30
25155756
Cancer Res. 2006 Feb 15;66(4):2000-11
16488999
Nature. 1999 May 20;399(6733):271-5
10353251
Nature. 2011 Oct 19;480(7375):94-8
22012259
Lancet Oncol. 2013 Feb;14 (2):159-67
23333114
Br J Cancer. 2016 Jan 12;114(1):76-80
26657656
Cancer Res. 2013 Apr 1;73(7):2044-51
23365135
Cancer. 2014 Apr 1;120(7):1059-67
24382589
Nat Genet. 2002 Apr;30(4):406-10
11865300
Med Res Rev. 2014 Jan;34(1):190-221
23720094
N Engl J Med. 2015 Nov 5;373(19):1872-4
26406149
Ann Oncol. 2013 Sep;24(9):2409-14
23788753
Br J Cancer. 2015 Mar 31;112(7):1190-8
25695485
Nat Genet. 1997 May;16(1):68-73
9140397
BJU Int. 2008 Apr;101(8):949-58
18241251
Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3387-92
11248088
Proc Natl Acad Sci U S A. 2016 Feb 23;113(8):2170-5
26864202
Lancet. 2016 Feb 27;387(10021):894-906
26318520
Nat Rev Urol. 2015 Dec;12(12):706-12
26526752
Elife. 2014 May 06;3:e02482
24843002
J Urol. 2003 Feb;169(2):710-3
12544348
Nat Genet. 2011 Dec 04;44(1):17-9
22138691
Pigment Cell Melanoma Res. 2010 Feb;23(1):27-40
19995375
Cancer Treat Rev. 2005 Nov;31(7):536-45
16236454
J Urol. 2009 Nov;182(5):2164-71
19758641
Adv Chronic Kidney Dis. 2014 Jan;21(1):81-90
24359990
Clin Cancer Res. 2013 Jun 15;19(12 ):3259-67
23620406
Lancet. 2009 Mar 28;373(9669):1119-32
19269025
Nat Genet. 2009 May;41(5):521-3
19330029
J Med Genet. 2015 Jun;52(6):426-30
25911086
Cell. 2015 Jun 18;161(7):1681-96
26091043
Nature. 2010 Jan 21;463(7279):360-3
20054297
Cancer Cell. 2011 Oct 18;20(4):511-23
22014576
Oncogene. 1999 Apr 8;18(14):2343-50
10327054
Genome Res. 2012 Nov;22(11):2089-100
23038766
BMC Cancer. 2008 Dec 24;8:387
19108730
N Engl J Med. 2015 Jun 25;372(26):2481-98
26061751
Br J Cancer. 2001 Sep 28;85(7):984-90
11592770
PLoS One. 2013 Sep 27;8(9):e76386
24086736
BJU Int. 2014 May;113(5b):E157-63
24053427
Mol Cell Biol. 2009 Aug;29(15):4080-90
19470762
Am J Hum Genet. 2013 Jun 6;92 (6):974-80
23684012
Hum Mol Genet. 2013 Feb 15;22(4):825-31
23184150
Nat Genet. 2012 May;44(5):570-4
22484628
Clin Cancer Res. 2016 May 15;22(10):2445-52
26831717
J Clin Oncol. 2013 Jan 10;31(2):181-6
23213094
Cancer Cell. 2002 Aug;2(2):157-64
12204536
Clin Cancer Res. 2014 Apr 1;20(7):1955-64
24622468
N Engl J Med. 2012 Mar 8;366(10):883-92
22397650
Nat Commun. 2015 Mar 19;6:6336
25790038
Mod Pathol. 2002 May;15(5):479-85
12011252
Oncoimmunology. 2014 Jan 1;3(1):e27810
24804162
Lancet Oncol. 2011 Nov;12 (12 ):1143-50
22015057
Int J Cancer. 2015 Mar 1;136(5):1104-16
24978482
N Engl J Med. 2015 Nov 5;373(19):1803-13
26406148
Nature. 2013 Jul 4;499(7456):43-9
23792563
Genome Biol. 2016 Apr 29;17:80
27139883
J Surg Oncol. 2003 Nov;84(3):166-72
14598361
Mol Cell. 2014 Sep 4;55(5):723-32
25066234
Nat Genet. 1994 May;7(1):85-90
7915601
Eur J Clin Pharmacol. 2015 Dec;71(12 ):1477-84
26387812
Cell Rep. 2014 Mar 27;6(6):973-81
24613357
Lancet Oncol. 2015 Jun;16(6):676-85
25979595
Mol Cancer Res. 2013 Sep;11(9):1061-71
23709298
J Urol. 1994 Mar;151(3):561-6
8308957
Sci Transl Med. 2012 Mar 28;4(127):127ps10
22461637
N Engl J Med. 2007 May 31;356(22):2271-81
17538086
Science. 1993 May 28;260(5112):1317-20
8493574
Genome Res. 2014 Feb;24(2):241-50
24158655
Int J Cancer. 1996 Jun 11;66(6):723-6
8647639
J Clin Invest. 2015 Dec;125(12):4625-37
26551685
Cancer Res. 2010 Feb 1;70(3):1063-71
20103651
J Urol. 2007 Jun;177(6):2074-9; discussion 2079-80
17509289
Nature. 2011 Jan 27;469(7331):539-42
21248752
Nat Rev Cancer. 2002 Jan;2(1):38-47
11902584
Nat Genet. 2013 Aug;45(8):860-7
23797736
PLoS One. 2015 Mar 31;10(3):e0122589
25826619
Curr Opin Oncol. 2011 May;23(3):283-9
21330923
Therapy. 2011 Jul;8(4):359-367
21894244
Eur Urol. 2016 Aug;70(2):348-57
26895810
Cell Rep. 2016 Mar 15;14 (10 ):2476-89
26947078
Eur Urol. 2015 Apr;67(4):740-9
24882670
Nat Rev Cancer. 2015 Jan;15(1):55-64
25533676
Br J Cancer. 2013 Mar 5;108(4):887-900
23462807
Clin Cancer Res. 2015 Jan 1;21(1):10-7
25564569
Curr Drug Targets. 2015;16(2):125-35
25619751
J Urol. 2008 Sep;180(3):860-5; discussion 865-6
18635227
Nature. 2013 Aug 22;500(7463):415-21
23945592
Oncologist. 2012;17(1):46-54
22234634
Oncoscience. 2015 Feb 20;2(2):81-90
25859550
N Engl J Med. 2016 Jan 14;374(2):135-45
26536169
Cell Rep. 2014 Jun 26;7(6):2006-18
24931610
Br J Cancer. 2015 Jun 30;113(1):12-9
26086878
Nature. 2015 Jan 29;517(7536):576-82
25631445
Nat Genet. 2014 Mar;46(3):225-33
24487277
Nat Commun. 2014 Oct 29;5:5135
25351205
Mol Cell Biol. 2005 Aug;25(15):6415-26
16024780
Cancer Genet. 2015 May;208(5):206-14
25873528
Nat Genet. 2012 Mar 11;44(4):420-5, S1-2
22406644
J Clin Oncol. 2010 Feb 20;28(6):1061-8
20100962
Nat Clin Pract Urol. 2007 Apr;4(4):205-17
17415353
Eur Urol. 2015 Jan;67(1):85-97
24857407
Nat Rev Urol. 2010 May;7(5):245-57
20448658
Int J Urol. 2009 May;16(5):432-43
19453547
J Natl Cancer Inst. 2005 Jun 15;97(12):931-5
15956655
N Engl J Med. 2013 Aug 22;369(8):722-31
23964934
Nat Rev Genet. 2014 Sep;15(9):585-98
24981601
Cell. 2013 Apr 25;153(3):590-600
23622243
Eur Urol. 2015 Apr;67(4):729-37
24836153
Int J Cancer. 2013 Jan 15;132(2):E11-7
22949125
N Engl J Med. 2014 Dec 4;371(23 ):2189-99
25409260
Am J Surg Pathol. 2004 Apr;28(4):435-41
15087662
J Biol Chem. 2007 Jul 13;282(28):20534-43
17502379
Clin Cancer Res. 2014 Jul 1;20(13):3411-21
24658158
PLoS Genet. 2011 Oct;7(10 ):e1002312
22022277
Sci Rep. 2015 Mar 06;5:8829
25743105
Nat Genet. 2013 Mar;45(3):253-61
23354438
N Engl J Med. 2000 Jun 8;342(23 ):1686-92
10841870
PLoS One. 2015 Oct 20;10 (10 ):e0140257
26484545
Lancet Oncol. 2013 Jan;14(1):81-7
23219378
Int J Cancer. 2015 Jun 15;136(12 ):2967-72
25403517
BJU Int. 2012 Jun;109(11):1600-6
22221668
Nat Genet. 2015 Jan;47(1):13-21
25401301
J Urol. 2016 Jan;195(1):180-7
26300218
J Clin Oncol. 2014 Jun 20;32(18):1968-76
24821879
Mod Pathol. 2015 Jun;28(6):845-53
25676555